These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38467087)

  • 21. Chromosomal copy number alterations are associated with persistent lymph node metastasis after chemoradiation in locally advanced rectal cancer.
    Chen Z; Liu Z; Deng X; Warden C; Li W; Garcia-Aguilar J
    Dis Colon Rectum; 2012 Jun; 55(6):677-85. PubMed ID: 22595848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer.
    Janjan NA; Abbruzzese J; Pazdur R; Khoo VS; Cleary K; Dubrow R; Ajani J; Rich TA; Goswitz MS; Evetts PA; Allen PK; Lynch PM; Skibber JM
    Radiother Oncol; 1999 May; 51(2):153-60. PubMed ID: 10435807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncologic outcomes of neoadjuvant chemoradiation for locally advanced rectal cancer: a single-institution experience.
    Leong YH; Leong CN; Tay GS; Sim R; Lopes G; Low W; Choo BA; Tey J
    Ann Acad Med Singap; 2014 Dec; 43(12):569-75. PubMed ID: 25588915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase II trial of neoadjuvant IMRT-based chemoradiotherapy followed by one cycle of capecitabine for stage II/III rectal adenocarcinoma.
    Zhu J; Gu W; Lian P; Sheng W; Cai G; Shi D; Cai S; Zhang Z
    Radiat Oncol; 2013 May; 8():130. PubMed ID: 23718210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neoadjuvant therapy for adenocarcinoma of the rectum: tumor response and acute toxicity.
    Read TE; McNevin MS; Gross EK; Whiteford HM; Lewis JL; Ratkin G; Picus J; Birnbaum EH; Fleshman JW; Kodner IJ; Myerson RJ
    Dis Colon Rectum; 2001 Apr; 44(4):513-22. PubMed ID: 11330578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of Poor Response to Neoadjuvant Chemoradiation in Patients With Rectal Cancer Using a DNA Repair Deregulation Score: Picking the Losers Instead of the Winners.
    Jimenez L; Perez RO; São Julião GP; Vailati BB; Fernandez LM; Gama-Rodrigues J; Habr-Gama A; DeVecchio J; Kalady MF; Camargo AA
    Dis Colon Rectum; 2020 Mar; 63(3):300-309. PubMed ID: 31842156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endoscopic Criteria for Evaluating Tumor Stage after Preoperative Chemoradiation Therapy in Locally Advanced Rectal Cancer.
    Han KS; Sohn DK; Kim DY; Kim BC; Hong CW; Chang HJ; Kim SY; Baek JY; Park SC; Kim MJ; Oh JH
    Cancer Res Treat; 2016 Apr; 48(2):567-73. PubMed ID: 26511812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe myositis of the hip flexors after pre-operative chemoradiation therapy for locally advanced rectal cancer: case report.
    Florczynski MM; Sanatani MS; Mai L; Fisher B; Moulin DE; Cao J; Louie AV; Pope JE; Leung E
    BMC Cancer; 2016 Mar; 16():243. PubMed ID: 27000107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The predictive value of clinical evaluation of response to neoadjuvant chemoradiation therapy for rectal cancer.
    Benzoni E; Cerato F; Cojutti A; Milan E; Pontello D; Chiaulon G; Sacco C; Bresadola V; Terrosu G
    Tumori; 2005; 91(5):401-5. PubMed ID: 16459636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer.
    Kim JS; Kim JS; Cho MJ; Song KS; Yoon WH
    Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):403-8. PubMed ID: 12243814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rab5C enhances resistance to ionizing radiation in rectal cancer.
    Baptistella AR; Landemberger MC; Dias MVS; Giudice FS; Rodrigues BR; da Silva PPCE; Cassinela EK; Lacerda TC; Marchi FA; Leme AFP; Begnami MD; Aguiar S; Martins VR
    J Mol Med (Berl); 2019 Jun; 97(6):855-869. PubMed ID: 30968159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of Dose-Escalated Chemoradiation on Complete Tumor Response in Patients with Locally Advanced Rectal Cancer (RECTAL-BOOST): A Phase 2 Randomized Controlled Trial.
    Couwenberg AM; Burbach JPM; Berbee M; Lacle MM; Arensman R; Raicu MG; Wessels FJ; Verdult J; Roodhart J; Reerink O; Hoendervangers S; Buijsen J; Grabsch HI; Pronk A; Consten ECJ; Smits AB; Heikens JT; Appelt AL; van Grevenstein WMU; Verkooijen HM; Intven MPW
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):1008-1018. PubMed ID: 32565319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different prognostic effect of postoperative chemoradiation therapy on diploid and nondiploid high-risk rectal cancers.
    Tang R; Ho YS; Chen HH; See LC; Wang JY
    Dis Colon Rectum; 1998 Dec; 41(12):1494-9. PubMed ID: 9860328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic role of the sialyltransferase ST6GAL1 in ovarian cancer.
    Wichert B; Milde-Langosch K; Galatenko V; Schmalfeldt B; Oliveira-Ferrer L
    Glycobiology; 2018 Nov; 28(11):898-903. PubMed ID: 30016515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated platelet count is a negative predictive and prognostic marker in locally advanced rectal cancer undergoing neoadjuvant chemoradiation: a retrospective multi-institutional study on 965 patients.
    Belluco C; Forlin M; Delrio P; Rega D; Degiuli M; Sofia S; Olivieri M; Pucciarelli S; Zuin M; De Manzoni G; Di Leo A; Scabini S; Zorcolo L; Restivo A
    BMC Cancer; 2018 Nov; 18(1):1094. PubMed ID: 30419864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of ST6GAL1 in Thyroid Cancers: Insights from Tissue Analysis and Genomic Datasets.
    Gunjača I; Benzon B; Pleić N; Babić Leko M; Pešutić Pisac V; Barić A; Kaličanin D; Punda A; Polašek O; Vukojević K; Zemunik T
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution of residual cancer cells in the bowel wall after neoadjuvant chemoradiation in patients with rectal cancer.
    Duldulao MP; Lee W; Streja L; Chu P; Li W; Chen Z; Kim J; Garcia-Aguilar J
    Dis Colon Rectum; 2013 Feb; 56(2):142-9. PubMed ID: 23303141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High Expression of VSTM2L Induced Resistance to Chemoradiotherapy in Rectal Cancer through Downstream IL-4 Signaling.
    Liu H; Zhang Z; Zhen P; Zhou M
    J Immunol Res; 2021; 2021():6657012. PubMed ID: 33506057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The predictive role of sequential FDG-PET/CT in response of locally advanced rectal cancer to neoadjuvant chemoradiation.
    Huh JW; Min JJ; Lee JH; Kim HR; Kim YJ
    Am J Clin Oncol; 2012 Aug; 35(4):340-4. PubMed ID: 21422901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of magnetic resonance volumetric evaluation in predicting response to preoperative concurrent chemoradiotherapy in patients with resectable rectal cancer.
    Kim YH; Kim DY; Kim TH; Jung KH; Chang HJ; Jeong SY; Sohn DK; Choi HS; Ahn JB; Kim DH; Lim SB; Lee JS; Park JG
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):761-8. PubMed ID: 15936557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.